TPST logo

Tempest Therapeutics (TPST) Company Overview

Profile

Full Name:

Tempest Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 12, 2012

Indexes:

Not included

Description:

Tempest Therapeutics (TPST) is a biotechnology company focused on developing innovative cancer treatments. They create therapies that target the immune system to fight tumors more effectively. Their goal is to improve patient outcomes and advance cancer care through cutting-edge research and development.

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 28, 2021

Analyst ratings

Recent major analysts updates

Nov 13, 24 Piper Sandler
Overweight
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 10, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jun 21, 24 Piper Sandler
Overweight
Jun 20, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
Mar 20, 24 HC Wainwright & Co.
Buy
Mar 14, 24 Scotiabank
Sector Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Tempest Therapeutics?
  • Does Tempest Therapeutics pay dividends?
  • What sector is Tempest Therapeutics in?
  • What industry is Tempest Therapeutics in?
  • What country is Tempest Therapeutics based in?
  • When did Tempest Therapeutics go public?
  • Is Tempest Therapeutics in the S&P 500?
  • Is Tempest Therapeutics in the NASDAQ 100?
  • Is Tempest Therapeutics in the Dow Jones?
  • When was Tempest Therapeutics's last earnings report?
  • When does Tempest Therapeutics report earnings?
  • Should I buy Tempest Therapeutics stock now?

What is the ticker symbol for Tempest Therapeutics?

The ticker symbol for Tempest Therapeutics is NASDAQ:TPST

Does Tempest Therapeutics pay dividends?

No, Tempest Therapeutics does not pay dividends

What sector is Tempest Therapeutics in?

Tempest Therapeutics is in the Healthcare sector

What industry is Tempest Therapeutics in?

Tempest Therapeutics is in the Biotechnology industry

What country is Tempest Therapeutics based in?

Tempest Therapeutics is headquartered in United States

When did Tempest Therapeutics go public?

Tempest Therapeutics's initial public offering (IPO) was on November 12, 2012

Is Tempest Therapeutics in the S&P 500?

No, Tempest Therapeutics is not included in the S&P 500 index

Is Tempest Therapeutics in the NASDAQ 100?

No, Tempest Therapeutics is not included in the NASDAQ 100 index

Is Tempest Therapeutics in the Dow Jones?

No, Tempest Therapeutics is not included in the Dow Jones index

When was Tempest Therapeutics's last earnings report?

Tempest Therapeutics's most recent earnings report was on Nov 12, 2024

When does Tempest Therapeutics report earnings?

The next expected earnings date for Tempest Therapeutics is Mar 19, 2025

Should I buy Tempest Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions